SUMA KURIAN: Open Payments
NPI 1548730195 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 13 payments from 10 companies in 2025. Trend: 2023 $1,130 · 2024 $1,184 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 1 | $137 |
| Actelion Pharmaceuticals US, Inc. | 1 | $137 |
| Amgen Inc. | 1 | $126 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Lilly USA, LLC | 1 | $122 |
| GlaxoSmithKline, LLC. | 2 | $54 |
| Verona Pharma, Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $18 |
Products named: Prolastin-C Liquid, UPTRAVI, TEZSPIRE, FASENRA, ZEPBOUND, NUCALA, Ohtuvayre, Sunosi.
Industry payments across FL — which companies pay providers there.
